Skip to content

Integrated Psychological therapy for Schizophrenia

Effectiveness of the Integrated Psychological Therapy in improving social functioning in patients with Schizophrenia - IPT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/12/005338
Enrollment
30
Registered
2014-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F200- Paranoid schizophrenia Health Condition 2: null- Schizophrenia and Schizoaffective disorders

Interventions

Intervention1: Psychological intervention ( Integrated Psychological Therapy: psychological therapy for 16-20 sessions that included social skills training and cognitive tasks Control Intervention1:

Sponsors

NIMHANS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Primary diagnosis of schizophrenia, or schizoaffective disorder, or Schizophreniform disorder (DSM IV TR) 2. Aged between 18-50 years. 3. Currently receiving treatment on outpatient basis 4. Maintained on the same dosage of medication in the two months prior to recruitment into the study and not been hospitalized in the two months prior to entry into the study 5. Minimum education up to Class V 6. English or Hindi speaking 7. Availability of a caregiver with whom patient is in contact

Exclusion criteria

Exclusion criteria: . Inpatients. . Co-morbid neurological conditions, history of head injury. .Co-morbid Axis I diagnosis of substance dependence syndrome, or current psychoactive substance abuse (except nicotine dependence), severe depression with psychotic symptoms. .Mental retardation on clinical assessment. .Patients who have undergone neuropsychological assessment in the six months prior to entry into the study. Patients who have received cognitive remediation or structured psychological therapy or social skills training in the past one year. Patients who have received electro-convulsive treatment (ECT) in the six months prior to being recruited for the present study.

Design outcomes

Primary

MeasureTime frame
social cognition, neurocognition, social functioning,Timepoint: Baseline, Post treatment and 3 month follow up

Secondary

MeasureTime frame
Psychiatric symptoms ( such as hallucinations, delusions, amotivation)Timepoint: baseline, post treatemnt and at 3 month follow-up

Countries

India

Contacts

Public ContactDr Paulomi M Sudhir

National Institute of Mental Health and Neurosciences

paulomi.sudhir@gmail.com919886176879

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026